Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Tan

Showing results (551-560 of 640) with videos related to

Pageof 64
Sort By:
Influenza and Other Respiratory Viruses|February 5, 2026
Investigation of a Family Cluster of Human Infections With Highly Pathogenic Avian Influenza A(H5N1) Virus, Clade 2.3.2.1e, in Cambodia, February 2023Savuth Chin, Chansovannara Soputhy, Heng Seng, et al.
Transfusion|September 5, 2018
Investigation of a case of suspected transfusion-transmitted malariaAnjoli Anand, Kimberly E Mace, Rebecca L Townsend, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2009
Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancerFabian Mc Johnston, Marcus C B Tan, Benjamin R Tan, et al.
Journal of Adolescent and Young Adult Oncology|June 1, 2023
Caring for Children in Relation to Financial Hardship, Advance Care Planning, and Genetic Testing Among Adolescent and Young Adults with CancerKelly R Tan, Clare Meernik, Chelsea Anderson, et al.
JCO Precision Oncology|January 31, 2025
Human Epidermal Growth Factor Receptor 2 Alterations and Prognostic Implications in All Subtypes of Breast CancersArielle L Heeke, Andrew Elliott, Kaitlyn O'Keefe, et al.
Cancer Chemotherapy and Pharmacology|August 30, 2019
A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumorsJanice M Mehnert, Amanda D Kaveney, Jyoti Malhotra, et al.
Vaccine: X|April 6, 2023
COVID-19 vaccine uptake trends in SARS-CoV-2 previously infected cancer patientsZainab Shahid, Alicia L Patrick, Michelle L Wallander, et al.
Investigational New Drugs|May 23, 2018
Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancerR S Finn, D H Ahn, M M Javle, et al.
The Lancet. Oncology|August 13, 2017
Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialSung-Bae Kim, Rebecca Dent, Seock-Ah Im, et al.
Cancer Chemotherapy and Pharmacology|October 20, 2021
A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignanciesAntoinette R Tan, Nancy Chan, Brian F Kiesel, et al.
Pageof 64

Showing results (551-560 of 640) with videos related to

Sort By:
Pageof 64
Influenza and Other Respiratory Viruses|February 5, 2026
Investigation of a Family Cluster of Human Infections With Highly Pathogenic Avian Influenza A(H5N1) Virus, Clade 2.3.2.1e, in Cambodia, February 2023Savuth Chin, Chansovannara Soputhy, Heng Seng, et al.
Transfusion|September 5, 2018
Investigation of a case of suspected transfusion-transmitted malariaAnjoli Anand, Kimberly E Mace, Rebecca L Townsend, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2009
Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancerFabian Mc Johnston, Marcus C B Tan, Benjamin R Tan, et al.
Journal of Adolescent and Young Adult Oncology|June 1, 2023
Caring for Children in Relation to Financial Hardship, Advance Care Planning, and Genetic Testing Among Adolescent and Young Adults with CancerKelly R Tan, Clare Meernik, Chelsea Anderson, et al.
JCO Precision Oncology|January 31, 2025
Human Epidermal Growth Factor Receptor 2 Alterations and Prognostic Implications in All Subtypes of Breast CancersArielle L Heeke, Andrew Elliott, Kaitlyn O'Keefe, et al.
Cancer Chemotherapy and Pharmacology|August 30, 2019
A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumorsJanice M Mehnert, Amanda D Kaveney, Jyoti Malhotra, et al.
Vaccine: X|April 6, 2023
COVID-19 vaccine uptake trends in SARS-CoV-2 previously infected cancer patientsZainab Shahid, Alicia L Patrick, Michelle L Wallander, et al.
Investigational New Drugs|May 23, 2018
Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancerR S Finn, D H Ahn, M M Javle, et al.
The Lancet. Oncology|August 13, 2017
Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialSung-Bae Kim, Rebecca Dent, Seock-Ah Im, et al.
Cancer Chemotherapy and Pharmacology|October 20, 2021
A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignanciesAntoinette R Tan, Nancy Chan, Brian F Kiesel, et al.
Pageof 64